Search

everythinglearnresearchcommunity

for

Search:↓

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

None of the tested compounds created a permanent mark on cattle.

Trichoscopy can help identify systemic diseases, not just hair and scalp issues.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

The conclusion is that it's important to tell apart alopecia areata from lipedematous alopecia for proper treatment, as alopecia areata can be reversed.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Alopecia areata may be caused by the immune system attacking hair follicles.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Ruxolitinib cream may help treat severe hair loss in children.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

GSH-T levels in hair follicles are similar in smokers and non-smokers and don't increase with certain treatments.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

Stem cells help control the immune response to improve wound healing.

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.

NXC736 significantly reduced hair loss in mice with alopecia areata.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.